Leslie Clark is an Oncology physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 158 publications with 1,452 citations (h-index 22); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
101 Manning Dr
Department Ob/gyn, Cb# 7570
Chapel Hill, NC 275144220
Telephone
919-966-5671Registry record last updated 21 Aug 2019.
Clinical trials
- MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback
Sponsor: UNC Lineberger Comprehensive Cancer Center
- Project Legacy Impact Evaluation Study
Sponsor: Children's Hospital Los Angeles
- A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium
Sponsor: UNC Lineberger Comprehensive Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Astellas Pharma US IncProgram year20251 payment
- GlaxoSmithKline, LLC.Program year20241 payment
- Davol Inc.Program year20232 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
50%Opioid Agonist22.1%Oxycodone Hcl100%Part D≥27 patientsGabapentinoids14.7%Gabapentin100%Part D<11 patients+ 1 more class in this area
Genitourinary & hormones
34.6%Estrogen22.1%Estradiol60%Estradiol (Twice Weekly)40%Part D<11 patientsbeta3-Adrenergic Agonist12.5%Myrbetriq100%Part D<11 patientsCancer & immunology
15.4%Aromatase Inhibitor15.4%Letrozole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Taking Care of Our Own: A Multispecialty Study of Resident and Program Director Perspectives on Contributors to Burnout and Potential Interventions
Carolina Digital Repository (University of North Carolina at Chapel Hill)
2024 - Asparagus officinalis Exhibits Anti-Tumorigenic and Anti-Metastatic Effects in Ovarian Cancer
Frontiers in Oncology
2021 - Contemporary Incidence of Medical Inoperability in Clinical Stage I Endometrial Cancer
Annals of Surgical Oncology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Robert Sandler, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Hyman Muss, MD
University of North Carolina at Chapel Hill
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”